Myriad Genetics (MYGN) News Today $8.06 +0.50 (+6.61%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$8.06 -0.01 (-0.06%) As of 10/3/2025 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MYGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by BrokeragesOctober 3 at 10:52 PM | marketbeat.comMyriad Genetics Announces Leadership Change in AccountingOctober 3 at 4:50 PM | tipranks.comMyriad Genetics (NASDAQ:MYGN) Shares Down 5.2% - Should You Sell?September 29, 2025 | marketbeat.comAssenagon Asset Management S.A. Buys 240,643 Shares of Myriad Genetics, Inc. $MYGNSeptember 27, 2025 | marketbeat.comMyriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid BiopsySeptember 23, 2025 | prnewswire.comMyriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid BiopsySeptember 23, 2025 | globenewswire.comA Look At The Fair Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)September 19, 2025 | finance.yahoo.comFiring on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the WaySeptember 17, 2025 | msn.comGoldman Sachs Group Inc. Sells 56,316 Shares of Myriad Genetics, Inc. $MYGNSeptember 16, 2025 | marketbeat.com1 Momentum Stock for Long-Term Investors and 2 Facing ChallengesSeptember 15, 2025 | msn.comMyriad Genetics (NASDAQ:MYGN) Stock Price Up 7% - What's Next?September 13, 2025 | marketbeat.comDynamic Technology Lab Private Ltd Makes New $531,000 Investment in Myriad Genetics, Inc. $MYGNSeptember 13, 2025 | marketbeat.comMyriad Genetics, Inc. (MYGN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comCubist Systematic Strategies LLC Sells 154,608 Shares of Myriad Genetics, Inc. $MYGNSeptember 10, 2025 | marketbeat.comGraham Capital Management L.P. Makes New $633,000 Investment in Myriad Genetics, Inc. $MYGNSeptember 8, 2025 | marketbeat.comPDT Partners LLC Makes New Investment in Myriad Genetics, Inc. $MYGNSeptember 6, 2025 | marketbeat.comMyriad Genetics' Precise MRD Test Demonstrates Effective Detection of ctDNA in Oligometastatic Clear-Cell Renal Cell Carcinoma PatientsSeptember 4, 2025 | quiverquant.comQMyriad Genetics Announces Precise MRD Clinical Data Published in The Lancet OncologySeptember 4, 2025 | globenewswire.comMyriad Genetics (NASDAQ:MYGN) Trading Up 6.4% - Still a Buy?September 4, 2025 | marketbeat.comMyriad Genetics Announces Meta-Analysis Results Indicating GeneSight Test Enhances Remission and Response Rates in Major Depressive Disorder PatientsSeptember 3, 2025 | quiverquant.comQNew Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with DepressionSeptember 3, 2025 | globenewswire.comWalleye Capital LLC Invests $1.66 Million in Myriad Genetics, Inc. $MYGNSeptember 1, 2025 | marketbeat.comJump Financial LLC Invests $1.19 Million in Myriad Genetics, Inc. $MYGNSeptember 1, 2025 | marketbeat.comMyriad Genetics, Inc. $MYGN Shares Purchased by Invesco Ltd.August 28, 2025 | marketbeat.comMyriad Genetics to Participate in Upcoming Investor Healthcare ConferencesAugust 27, 2025 | globenewswire.comWellington Management Group LLP Sells 1,412,334 Shares of Myriad Genetics, Inc. $MYGNAugust 26, 2025 | marketbeat.comAlgert Global LLC Has $1.60 Million Position in Myriad Genetics, Inc. $MYGNAugust 25, 2025 | marketbeat.comNuveen LLC Invests $10.44 Million in Myriad Genetics, Inc. $MYGNAugust 25, 2025 | marketbeat.comMyriad Genetics, Inc. $MYGN Shares Acquired by Vanguard Group Inc.August 25, 2025 | marketbeat.comPublic Sector Pension Investment Board Acquires 61,270 Shares of Myriad Genetics, Inc. $MYGNAugust 22, 2025 | marketbeat.comANGLE plc partners with Myriad Genetics to advance cancer diagnosticsAugust 20, 2025 | msn.comANGLE (ANPCF) Partners with Myriad Genetics to Enhance Cancer DiagnosticsAugust 20, 2025 | gurufocus.comANGLE Announces Collaboration with Myriad Genetics | ANPCY Stock NewsAugust 20, 2025 | gurufocus.comMyriad Genetics reaffirms FY25 guidanceAugust 19, 2025 | msn.comMyriad Genetics, Inc.: Myriad Genetics Appoints Ben Wheeler Chief Financial OfficerAugust 18, 2025 | finanznachrichten.deMyriad Genetics Appoints Ben Wheeler Chief Financial Officer | MYGN Stock NewsAugust 18, 2025 | gurufocus.comBen Wheeler Steps Up as CFO at Myriad Genetics (MYGN)August 18, 2025 | gurufocus.comMyriad Genetics Appoints Ben Wheeler Chief Financial OfficerAugust 18, 2025 | gurufocus.comMyriad Genetics Appoints Ben R. Wheeler as CFOAugust 18, 2025 | tipranks.comMyriad Genetics announces CFO appointmentAugust 18, 2025 | seekingalpha.comMyriad Genetics Appoints Ben Wheeler Chief Financial OfficerAugust 18, 2025 | globenewswire.comMyriad Genetics, Inc. (NASDAQ:MYGN) Shares Sold by XTX Topco LtdAugust 15, 2025 | marketbeat.comMyriad Genetics’s Q2 Earnings Call: Our Top 5 Analyst QuestionsAugust 13, 2025 | finance.yahoo.comMYGN Q2 Deep Dive: Oncology Strategy Shift and Product Execution Shape GuidanceAugust 13, 2025 | finance.yahoo.comMyriad Genetics Reveals Insights from Cancer Risk Survey Highlighting Women's Attitudes Toward Health ScreeningsAugust 13, 2025 | quiverquant.comQNew Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the ResultsAugust 13, 2025 | globenewswire.comConnor Clark & Lunn Investment Management Ltd. Buys 372,455 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)August 13, 2025 | marketbeat.comMyriad Genetics’ Earnings Call: Growth Amid ChallengesAugust 13, 2025 | theglobeandmail.com3 Reasons MYGN is Risky and 1 Stock to Buy InsteadAugust 13, 2025 | msn.comKnott David M Jr Invests $1.42 Million in Myriad Genetics, Inc. (NASDAQ:MYGN)August 12, 2025 | marketbeat.com Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MYGN Media Mentions By Week MYGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYGN News Sentiment▼0.960.54▲Average Medical News Sentiment MYGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYGN Articles This Week▼38▲MYGN Articles Average Week Get the Latest News and Ratings for MYGN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Myriad Genetics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies FOLD News CLDX News MNKD News BCRX News NVAX News INVA News OPK News DVAX News ZBIO News GERN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYGN) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
